
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6388688
[patent_doc_number] => 20100317690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'TREATMENT OF PROTEIN FOLDING DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/744029
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11439
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317690.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744029
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744029 | TREATMENT OF PROTEIN FOLDING DISORDERS | Nov 19, 2008 | Abandoned |
Array
(
[id] => 5558926
[patent_doc_number] => 20090270503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'NUTRITIONAL SUPPLEMENTS'
[patent_app_type] => utility
[patent_app_number] => 12/260794
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9603
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270503.pdf
[firstpage_image] =>[orig_patent_app_number] => 12260794
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/260794 | NUTRITIONAL SUPPLEMENTS | Oct 28, 2008 | Abandoned |
Array
(
[id] => 5485882
[patent_doc_number] => 20090275647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'TAXANE DERIVATIVE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/259634
[patent_app_country] => US
[patent_app_date] => 2008-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1877
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12259634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/259634 | TAXANE DERIVATIVE COMPOSITION | Oct 27, 2008 | Abandoned |
Array
(
[id] => 10024980
[patent_doc_number] => 09066858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Pharmaceutical composition for the sublingual administration of progesterone, and method for its preparation'
[patent_app_type] => utility
[patent_app_number] => 12/734078
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2001
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12734078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734078 | Pharmaceutical composition for the sublingual administration of progesterone, and method for its preparation | Oct 9, 2008 | Issued |
Array
(
[id] => 6494648
[patent_doc_number] => 20100209513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED PARTICLES OF NAPHTHOQUINONE-BASED COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/682504
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13972
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209513.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682504 | PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED PARTICLES OF NAPHTHOQUINONE-BASED COMPOUND | Oct 6, 2008 | Abandoned |
Array
(
[id] => 6537665
[patent_doc_number] => 20100204247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 12/678820
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13098
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204247.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678820
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678820 | N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Sep 29, 2008 | Abandoned |
Array
(
[id] => 5521978
[patent_doc_number] => 20090029959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants'
[patent_app_type] => utility
[patent_app_number] => 12/238751
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7939
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029959.pdf
[firstpage_image] =>[orig_patent_app_number] => 12238751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/238751 | Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants | Sep 25, 2008 | Abandoned |
Array
(
[id] => 6507935
[patent_doc_number] => 20100210613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Transdermally Absorbable Preparation'
[patent_app_type] => utility
[patent_app_number] => 12/677388
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7502
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677388
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677388 | Transdermally absorbable preparation | Sep 9, 2008 | Issued |
Array
(
[id] => 5576064
[patent_doc_number] => 20090143426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments'
[patent_app_type] => utility
[patent_app_number] => 12/283215
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21078
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143426.pdf
[firstpage_image] =>[orig_patent_app_number] => 12283215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/283215 | Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments | Sep 9, 2008 | Abandoned |
Array
(
[id] => 5509130
[patent_doc_number] => 20090082337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Compositions Comprising Quinolone and Methods for Treating or Controlling Infections'
[patent_app_type] => utility
[patent_app_number] => 12/205946
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10428
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082337.pdf
[firstpage_image] =>[orig_patent_app_number] => 12205946
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/205946 | Compositions Comprising Quinolone and Methods for Treating or Controlling Infections | Sep 7, 2008 | Abandoned |
Array
(
[id] => 5429084
[patent_doc_number] => 20090088394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/204213
[patent_app_country] => US
[patent_app_date] => 2008-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 40664
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088394.pdf
[firstpage_image] =>[orig_patent_app_number] => 12204213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/204213 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | Sep 3, 2008 | Abandoned |
Array
(
[id] => 5272277
[patent_doc_number] => 20090076053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/203703
[patent_app_country] => US
[patent_app_date] => 2008-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41171
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076053.pdf
[firstpage_image] =>[orig_patent_app_number] => 12203703
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/203703 | METHODS AND COMPOSITIONS FOR TREATING PAIN | Sep 2, 2008 | Abandoned |
Array
(
[id] => 8870821
[patent_doc_number] => 08466198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Compositions comprising creatine salts and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/202944
[patent_app_country] => US
[patent_app_date] => 2008-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4653
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12202944
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/202944 | Compositions comprising creatine salts and methods of use thereof | Sep 1, 2008 | Issued |
Array
(
[id] => 5392295
[patent_doc_number] => 20090209608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'DEUTERIUM-ENRICHED ASENAPINE'
[patent_app_type] => utility
[patent_app_number] => 12/195529
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3884
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195529
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195529 | DEUTERIUM-ENRICHED ASENAPINE | Aug 20, 2008 | Abandoned |
Array
(
[id] => 9524157
[patent_doc_number] => 08748422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist'
[patent_app_type] => utility
[patent_app_number] => 12/195951
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8951
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12195951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195951 | Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist | Aug 20, 2008 | Issued |
Array
(
[id] => 6594873
[patent_doc_number] => 20100048535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Method and dosage regimens for eliminating a chemical substance in blood'
[patent_app_type] => utility
[patent_app_number] => 12/195143
[patent_app_country] => US
[patent_app_date] => 2008-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12366
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048535.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195143 | Method and dosage regimens for eliminating a chemical substance in blood | Aug 19, 2008 | Issued |
Array
(
[id] => 6203009
[patent_doc_number] => 20110065795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => '(1S,2S,3S,4R)-3-[(1S)-1-ACETYLAMINO-2-ETHYL-BUTYL]-4-UANIDINO-2-HYDROXYL-CYCLOPENTYL-1-CARBOXYLIC ACID HYDRATES PHARMACEUTICAL USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/673355
[patent_app_country] => US
[patent_app_date] => 2008-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15489
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065795.pdf
[firstpage_image] =>[orig_patent_app_number] => 12673355
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/673355 | (1S,2S,3S,4R)-3-[(1S)-1-ACETYLAMINO-2-ETHYL-BUTYL]-4-UANIDINO-2-HYDROXYL-CYCLOPENTYL-1-CARBOXYLIC ACID HYDRATES PHARMACEUTICAL USES THEREOF | Aug 12, 2008 | Abandoned |
Array
(
[id] => 5527815
[patent_doc_number] => 20090197892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'ANHYDROUS COMPOSITIONS USEFUL FOR ATTAINING ENHANCED SEXUAL WELLNESS'
[patent_app_type] => utility
[patent_app_number] => 12/189837
[patent_app_country] => US
[patent_app_date] => 2008-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9705
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197892.pdf
[firstpage_image] =>[orig_patent_app_number] => 12189837
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189837 | ANHYDROUS COMPOSITIONS USEFUL FOR ATTAINING ENHANCED SEXUAL WELLNESS | Aug 11, 2008 | Abandoned |
Array
(
[id] => 4710677
[patent_doc_number] => 20080299203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Solid Pharmaceutical Dosage Formulation'
[patent_app_type] => utility
[patent_app_number] => 12/190252
[patent_app_country] => US
[patent_app_date] => 2008-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13203
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299203.pdf
[firstpage_image] =>[orig_patent_app_number] => 12190252
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/190252 | Solid Pharmaceutical Dosage Formulation | Aug 11, 2008 | Abandoned |
Array
(
[id] => 7791664
[patent_doc_number] => 20120053220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/671567
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11542
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053220.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671567
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671567 | NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS | Jul 31, 2008 | Abandoned |